Ananda Basu MD
Diabetes, Lipid Metabolism
Professor, Family Medicine, Mayo Medical School
Join to View Full Profile
2000 6th Ave SBirmingham, AL 35233
Phone+1 205-934-9999
Fax+1 434-972-4266
Dr. Basu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1994 - 1997
- Mayo Clinic College of MedicineClass of 1985
Certifications & Licensure
AL State Medical License 2023 - 2025
VA State Medical License 2017 - 2024
MN State Medical License 1997 - 2017
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes Start of enrollment: 2010 Feb 01
- USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes Start of enrollment: 2014 Jun 01
- At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 1 citationsYoung‐onset diabetes, nutritional therapy and novel insulin delivery systems: a report from the 21st Hong Kong Diabetes and Cardiovascular Risk Factors – East Meets We...Andrea O.Y. Luk, Alice P.S. Kong, Ananda Basu
Diabetic Medicine. 2020-06-08 - 18 citationsBeyond HbA1c : using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making.Sue A. Brown, Ananda Basu, B Kovatchev
Diabetic Medicine. 2019-06-01 - 21 citationsOverexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic miceMinglin Pan, Ying Han, Aninda Basu, Anzhi Dai, Rui Si
American Journal of Physiology. Cell Physiology. 2018-06-01
Journal Articles
- Paradigm Shifts in Nocturnal Glucose Control in Type 2 DiabetesRobert A Rizza, Ananda Basu, Rita Basu, The Journal of Clinical Endocrinology and Metabolism
Lectures
- Differential Regulation of Glucocorticoids and Insulin on Hepatic 11ß-Hydroxysteroid Dehydrogenase Type 1 Enzyme ActivityRochester, MN - 6/16/2014
- Glucagon-Like Peptide 1 Modulates Reductions in Myocardial Blood Flow Reserve during Euglycemia and Hyperglycemia in Both Type 2 Diabetics and Non-DiabeticsRochester, MN - 6/15/2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
